Autoimmune Hepatitis
Autoimmune hepatitis (AIH) is a chronic inflammatory liver disease in which the immune system attacks liver cells. It can occur at any age and may present with abnormal liver enzymes, fatigue, jaundice, or features of chronic liver disease.
There is no single blood test that confirms autoimmune hepatitis. Diagnosis usually involves a combination of liver function tests, autoimmune antibodies, immunoglobulin testing, exclusion of viral and other causes of liver disease, and sometimes liver biopsy.
At National Path Lab (NPL), laboratory investigations support the evaluation of suspected autoimmune hepatitis and help clinicians assess liver inflammation and associated autoimmune markers.
- Tests available
- 12
- Tests available
Tests Available at NPL
GAMMA GLUTAMYL TRANSFERASE; GGT
SAMPLE DAILY BY 7:00 PM REPORT ON SAME DAY
Rs. 900
LIVER KIDNEY MICROSOMAL (LKM) ANTIBODY, IFA
SAMPLE BY MON, WED & FRI 8:00 AM REPORT ON SAME DAY EVENING
Rs. 3500
ANTI SOLUBLE LIVER ANTIGEN; SLA, EIA
SAMPLE BY SUN & WED 8:00 AM REPORT ON SAME DAY EVENING
Rs. 2200
SGOT; ASPARTATE AMINOTRANSFERASE (AST)
SAMPLE DAILY BY 7:00 PM REPORT ON SAME DAY
Rs. 300
IMMUNOGLOBULIN IGG
SAMPLE DAILY BY 7:00 PM REPORT ON SAME DAY
Rs. 1500
SGPT; ALANINE AMINOTRANSFERASE (ALT)
SAMPLE DAILY BY 7:00 PM REPORT ON SAME DAY
Rs. 300
SMOOTH MUSCLE ANTIBODY (ASMA), IFA
SAMPLE BY MON, WED & FRI 8:00 AM REPORT ON SAME DAY EVENING
Rs. 3500
ALBUMIN, SERUM
SAMPLE DAILY BY 7:00 PM REPORT ON SAME DAY
Rs. 200
ALKALINE PHOSPHATASE (ALKP), SERUM
SAMPLE DAILY BY 7:00 PM REPORT ON SAME DAY
Rs. 200
BILLIRUBIN DIRECT/INDIRECT/TOTAL
SAMPLE DAILY BY 7:00 PM REPORT ON SAME DAY
Rs. 400
ANTI NUCLEAR ANTIBODY; ANA; IFA, END POIN TITRE
SAMPLE DAILY BY 8:00 AM REPORT ON SAME DAY EVENING
Rs. 2500
PROTHROMBIN TIME; PT INR
SAMPLE DAILY BY 7:00 PM REPORT ON SAME DAY
Rs. 500
About Autoimmune Hepatitis
Causes & Risk Factors
AIH is thought to arise from a combination of genetic susceptibility and an immune-triggering event, resulting in the immune system attacking liver tissue.
• Sex — AIH is more common in women than men, similar to many other autoimmune diseases.
• Age — can occur at any age, from childhood through late adulthood, with two recognized types (Type 1 and Type 2) that tend to present at different ages.
• Genetic predisposition — certain genetic markers are associated with increased susceptibility.
• Coexisting autoimmune disease — AIH may occur alongside other autoimmune conditions, including thyroid disease, type 1 diabetes, or autoimmune conditions affecting the gut or joints.
• Possible environmental triggers — certain infections or medications have been proposed as potential triggers in susceptible individuals, though this is not fully established.
Symptoms & When to Test
AIH may be discovered incidentally through abnormal liver enzymes, or may present with more specific symptoms of liver disease.
• Persistent unexplained elevation of ALT or AST
• Recurrent abnormal liver function tests
• Unexplained hepatitis
• Jaundice (yellowing of skin or eyes)
• Elevated serum IgG
• Unexplained fatigue
• Other known autoimmune diseases with new liver test abnormalities
• Features suggesting chronic liver disease
When Should You Consider Testing?
Testing may be considered in patients with persistent unexplained elevation of ALT or AST, recurrent abnormal liver function tests, unexplained hepatitis, jaundice, elevated serum IgG, other autoimmune diseases, suspected chronic liver disease, or liver abnormalities without an obvious cause.
Why Tests Are Combined
Abnormal liver enzymes can have many causes — viral hepatitis, fatty liver disease, alcohol-associated liver disease, drug-induced injury, hemochromatosis, Wilson disease, and other autoimmune liver diseases can all present similarly. A combination of investigations is therefore more useful than ordering a single autoimmune marker.
ANA and ASMA/SMA are commonly used together when evaluating suspected Type 1 AIH, since either can be positive, and both provide complementary supportive evidence.
Elevated Total IgG is an important supportive feature but is not specific to AIH on its own; it is interpreted together with autoantibodies, liver enzymes, and clinical findings (IgG + Autoantibodies + Liver Enzymes + Clinical Findings) rather than in isolation.
In autoantibody-negative or unclear cases, additional markers such as Anti-LKM-1 and Anti-SLA/LP may be added, since these can be positive even when the more common antibodies are negative — particularly relevant in suspected Type 2 AIH.
Tests Available at NPL
Test Code | Test | Clinical Relevance |
B0063
| SGPT; ALANINE AMINOTRANSFERASE (ALT) | Helps assess hepatocellular liver injury and is often elevated in autoimmune hepatitis. |
B0062 | SGOT; ASPARTATE AMINOTRANSFERASE (AST) | Evaluates liver cell injury and is interpreted together with ALT and other liver tests. |
B0095
| IMMUNOGLOBULIN IGG | Elevated IgG is an important laboratory feature in many patients with autoimmune hepatitis. |
I0025
| ANTI NUCLEAR ANTIBODY; ANA; IFA, END POINT TITRE | One of the important autoantibodies evaluated in suspected autoimmune hepatitis; more common in Type 1 AIH. |
I0081
| SMOOTH MUSCLE ANTIBODY (ASMA), IFA | Anti-Smooth Muscle Antibody; commonly associated with Type 1 autoimmune hepatitis. |
I0061
| LIVER KIDNEY MICROSOMAL (LKM) ANTIBODY, IFA | May be useful in selected patients, particularly when Type 2 autoimmune hepatitis is being considered. |
I0122
| ANTI SOLUBLE LIVER ANTIGEN; SLA, EIA | A relatively specific marker that may support diagnosis in selected patients, particularly when other antibodies are negative. |
B0008 B0074
| ALKALINE PHOSPHATASE (ALKP), SERUM and GAMMA GLUTAMYL TRANSFERASE; GGT | Help assess the pattern of liver enzyme abnormality and may assist in distinguishing hepatocellular from cholestatic disease. |
B0012
| BILLIRUBIN DIRECT/INDIRECT/TOTAL | Evaluates bilirubin metabolism and may be elevated in clinically active disease. |
B0007
| ALBUMIN, SERUM | Provides information about liver synthetic function, particularly in chronic or advanced disease. |
H0031
| PROTHROMBIN TIME; PT INR | Helps assess hepatic synthetic function and may be important in patients with significant liver dysfunction. |
Which Tests Do I Need?
Abnormal ALT/AST With Suspected Autoimmune Cause
→ ALT
→ AST
→ Total IgG
→ ANA
→ ASMA/SMA
Suspected Type 2 Autoimmune Hepatitis
→ Total IgG
→ ANA
→ ASMA/SMA
→ Anti-LKM-1
Autoantibody-Negative or Unclear Cases
→ Total IgG
→ ANA
→ ASMA/SMA
→ Anti-LKM-1
→ Anti-SLA/LP
→ Additional evaluation based on clinical findings
Suspected Autoimmune Liver Disease / Cholestatic Pattern
→ ALT/AST
→ ALP/GGT
→ Bilirubin
→ ANA
→ AMA
→ IgG/other immunoglobulin assessment where indicated
Most autoimmune antibody tests and inflammatory markers do not require fasting. However, if your doctor has ordered other tests at the same time — such as glucose or lipid testing — fasting may be required for those investigations. Please follow the preparation instructions provided by your doctor or NPL.
Home Sample Collection
NPL offers convenient home sample collection for all Autoimmune Hepatitis tests, so you don't need to visit a lab in person.
→ Book your test online, via the NPL app, or by calling +977 1 5970147 and select a convenient time slot for home sample collection.
→ A certified and experienced NPL phlebotomist visits your home at the scheduled time, following strict hygiene and safety protocols.
→ Your sample is transported under controlled, monitored conditions to NPL's NABL ACCREDITED UNDER ISO 15189:2022 laboratory for processing.
→ Your digital report is delivered securely to your phone or email, along with access to download and share it as needed.
When to See a Doctor
• Persistent unexplained elevation of liver enzymes
• Jaundice (yellowing of the skin or eyes)
• Unexplained fatigue combined with abnormal liver tests
• Elevated IgG on routine blood work
• Recurrent abnormal liver function tests
• Known autoimmune disease with new abnormal liver tests
• Unexplained chronic liver disease
• Positive autoimmune liver antibodies on prior testing
Medical Disclaimer Laboratory tests support the evaluation and monitoring of autoimmune hepatitis but should not be interpreted in isolation. Positive autoimmune antibodies do not necessarily mean that a person has autoimmune hepatitis. Results should be interpreted together with clinical history, liver biochemistry, imaging, and other investigations by a qualified healthcare professional. |
